Alcohol
Volume 34, Issue 1 , Pages 9-19 , August 2004

Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis

  • Charles S. Lieber

      Affiliations

    • Corresponding Author InformationCorresponding author. Bronx Veterans Affairs Medical Center, 130 West Kingsbridge Road (151-2), Bronx, NY 10468, USA. Tel.: +1-718-741-4244; fax: +1-718-733-6257.

Received 30 March 2004 ,Revised 16 July 2004 ,Accepted 20 July 2004.

References 

  1. Adas F, Berthou F, Picart D, Lozac'h P, Beaugé F, Amet Y. Involvement of cytochrome P450 2E1 in the (ω–1)-hydroxylation of oleic acid in human and rat liver microsomes. J Lipid Res. 1998;39:1210–1219
  2. Aleynik MK, Leo MA, Aleynik SI, Lieber CS. Polyenylphosphatidylcholine opposes the increase of cytochrome P-4502E1 by ethanol and corrects its iron-induced decrease. Alcohol Clin Exp Res. 1999;23:96–100
  3. Aleynik MK, Lieber CS. Dilinoleoylphosphatidylcholine decreases ethanol-induced cytochrome P4502E1. Biochem Biophys Res Commun. 2001;288:1047–1051
  4. Amet Y, Berthou F, Goasduff T, Salaun JP, Le Breton L, Menez JF. Evidence that cytochrome P450 2E1 is involved in the (ω-1)-hydroxylation of lauric acid in rat liver microsomes. Biochem Biophys Res Commun. 1994;203:1168–1174
  5. Angulo P, Lindor KD. Insulin resistance and mitochondrial abnormalities in NASH: a cool look into a burning issue. Gastroenterology. 2001;120:1281–1285(Editorial)
  6. Arai M, Gordon ER, Lieber CS. Decreased cytochrome oxidase activity in hepatic mitochondria after chronic ethanol consumption and the possible role of decreased cytochrome aa3 content and changes in phospholipids. Biochim Biophys Acta. 1984;797:320–327
  7. Baraona, E., Matsumura, T., Hernandez, R., Kubota, S., Soong, J., Kawano, S., Kato, S., Inatomi, N., Sato, S., & Lieber, C.S. (1988). Chronic alcohol intake impairs liver oxygenation by decreasing O2 utilization. In K. Kuriyama, A. Takada, & H. Ishii (Eds.), Biomedical and Social Aspects of Alcohol and Alcoholism: Proceedings of the Fourth Congress of the International Society for Biomedical Research on Alcoholism (pp. 387–390). Amsterdam, The Netherlands: Elsevier Science Publishers BV.
  8. Batey R, Cao Q, Madsen G, Pang G, Russell A, Clancy R. Decreased tumor necrosis factor-α and interleukin-1α production from intrahepatic mononuclear cells in chronic ethanol consumption and upregulation by endotoxin. Alcohol Clin Exp Res. 1998;22:150–156
  9. Best CH, Hartroft WS, Lucas CC, Ridout JH. Liver damage produced by feeding alcohol or sugar and its prevention by choline. Br Med J. 1949;2:1001–1006
  10. Bird GLA, Panos MZ, Polson R, Johnson R, Portman B, Neuberger J, et al. Activity of polyunsaturated phosphatidylcholine in HbsAg negative chronic active hepatitis and acute alcoholic hepatitis. Z Gastroenterol. 1991;29:21–24
  11. Boleda MD, Saubi N, Farrés J, Parés X. Physiological substrates for rat alcohol dehydrogenase classes: aldehydes of lipid peroxidation, ω-hydroxyfatty acids, and retinoids. Arch Biochem Biophys. 1993;307:85–90
  12. Burnett DA, Lysenko N, Manning JA, Ockner RK. Utilization of long chain fatty acids by rat liver: studies of the role of fatty acid binding protein. Gastroenterology. 1979;77:241–249
  13. Cao Q, Mak KM, Lieber CS. DLPC decreases TGFβ1-induced collagen mRNA by inhibiting p38 MAPK in hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol. 2002;283:G1051–G1061
  14. Casazza JP, Felver ME, Veech RL. The metabolism of acetone in rat. J Biol Chem. 1984;259:231–236
  15. Casazza JP, Veech RL. The production of 1,2-propanediol in ethanol treated rats. Biochem Biophys Res Commun. 1985;129:426–430
  16. Casini A, Cunningham M, Rojkind M, Lieber CS. Acetaldehyde increases procollagen type I and fibronectin gene transcription in cultured rat fat-storing cells through a protein synthesis-dependent mechanism. Hepatology. 1991;13:758–765
  17. Chedid A, Mendenhall CL, Gartside P, French SW, Chen T, Rabin L, et al. Prognostic factors in alcoholic liver disease. Am J Gastroenterol. 1991;86:210–216
  18. Conney AH. Pharmacological implications of microsomal enzyme induction. Pharmacol Rev. 1967;19:317–366
  19. de la Maza MP, Petermann M, Bunout D, Hirsch S. Effects of long-term vitamin E supplementation in alcoholic cirrhotics. J Am Coll Nutr. 1995;14:192–196
  20. Duce AM, Ortiz P, Cabrero C, Mato JM. S-adenosyl-lmethionine synthetase and phospholipid methyltransferase are inhibited in human cirrhosis. Hepatology. 1988;8:65–68
  21. Eriksson CJP, Fukunaga T, Sarkola T, Lindholm H, Ahola L. Estrogen-related acetaldehyde elevation in women during alcohol intoxication. Alcohol Clin Exp Res. 1996;20:1192–1195
  22. Espina N, Lima V, Lieber CS, Garro AJ. In vitro and in vivo inhibitory effect of ethanol and acetaldehyde on O6-methylguanine transferase. Carcinogenesis. 1988;9:761–766
  23. Ferenci P, Dragosics B, Dittrich H, Frank H, Benda L, Lochs H, et al. Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver. J Hepatol. 1989;9:105–113
  24. Frezza M, di Padova C, Pozzato G, Terpin M, Baraona E, Lieber CS. High blood alcohol levels in women. The role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism. N Engl J Med. 1990;322:95–99
  25. Frezza M, Surrenti C, Manzillo G, Fiaccadori F, Bortolini M, Di Padova C. Oral S-adenosylmethionine in the symptomatic treatment of intrahepatic cholestasis. A double-blind, placebo-controlled study. Gastroenterology. 1990;99:211–215
  26. Galli A, Price D, Crabb D. High-level expression of rat class I alcohol dehydrogenase is sufficient for ethanol-induced fat accumulation in transduced HeLa cells. Hepatology. 1999;29:1164–1170
  27. Hasumura Y, Teschke R, Lieber CS. Characteristics of acetaldehyde oxidation in rat liver mitochondria. J Biol Chem. 1976;251:4908–4913
  28. Hoerner M, Behrens UJ, Worner T, Lieber CS. Humoral immune response to acetaldehyde adducts in alcoholic patients. Res Commun Chem Pathol Pharmacol. 1986;54:3–12
  29. Iseri OA, Gottlieb LS, Lieber CS. The ultrastructure of ethanol induced fatty liver. Fed Proc. 1964;23:579A;(Abstract)
  30. Iseri OA, Lieber CS, Gottlieb LS. The ultrastructure of fatty liver induced by prolonged ethanol ingestion. Am J Pathol. 1966;48:535–555
  31. Ishii H, Joly J-G, Lieber CS. Effect of ethanol on the amount and enzyme activities of hepatic rough and smooth microsomal membranes. Biochim Biophys Acta. 1973;291:411–420
  32. Ishii H, Joly J-G, Lieber CS. Increase of microsomal glucose-6-phosphatase activity after chronic ethanol administration. Metabolism. 1973;22:799–806
  33. Isselbacher KJ, Carter EA. Ethanol oxidation by liver microsomes: evidence against a separate and distinct enzyme system. Biochem Biophys Res Commun. 1970;39:530–537
  34. James OFW, Day CP. Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance. J Hepatol. 1998;29:495–501
  35. Johansson I, Eliasson E, Norsten C, Ingelman-Sundberg M. Hydroxylation of acetone by ethanol- and acetone-inducible cytochrome P-450 in liver microsomes and reconstituted membranes. FEBS Lett. 1986;196:59–64
  36. Jones BM, Jones MK. Male and female intoxication levels for three alcohol doses or do women really get higher than men?. Alcohol Technical Report. 1976;5:544–583
  37. Kaikaus RM, Chan WK, Ortiz de Montellano PR, Bass NM. Mechanisms of regulation of liver fatty acid–binding protein. Mol Cell Biochem. 1993;123:93–100
  38. Kato J, Sato Y, Inui N, Nakano Y, Takimoto R, Takada K, et al. Ethanol induces transforming growth factor-α expression in hepatocytes, leading to stimulation of collagen synthesis by hepatic stellate cells. Alcohol Clin Exp Res. 2003;27(8 Suppl):58S–63S
  39. Khani SC, Porter TD, Coon MJ. Isolation and partial characterization of the gene for cytochrome P-450 3a (P-450ALC) and a second closely related gene. Biochem Biophys Res Commun. 1988;150:10–17
  40. Koivisto T, Mishin VM, Mak KM, Cohen PA, Lieber CS. Induction of cytochrome P-4502E1 by ethanol in rat Kupffer cells. Alcohol Clin Exp Res. 1996;20:207–212
  41. Koop DR. Oxidative and reductive metabolism by cytochrome P450 2E1. FASEB J. 1992;6:724–730
  42. Koop DR, Casazza JP. Identification of ethanol-inducible P-450 isozyme 3a as the acetone and acetol monooxygenase of rabbit microsomes. J Biol Chem. 1985;260:13607–13612
  43. Koop DR, Tierney DJ. Multiple mechanisms in the regulation of ethanol-inducible cytochrome P450IIE1. Bioessays. 1990;12:429–435
  44. Laethem RM, Balazy M, Falck JR, Laethem CL, Koop DR. Formation of 19(S)-, 19(R)-, and 18(R)-hydroxyeicosatetraenoic acids by alcohol-inducible cytochrome P450 2E1. J Biol Chem. 1993;268:12912–12918
  45. Lane BP, Lieber CS. Ultrastructural alterations in human hepatocytes following ingestion of ethanol with adequate diets. Am J Pathol. 1966;49:593–603
  46. Lane BP, Lieber CS. Effects of butylated hydroxytoluene on the ultrastructure of rat hepatocytes. Lab Invest. 1967;16:342–348
  47. Leo MA, Rosman AS, Lieber CS. Differential depletion of carotenoids and tocopherol in liver disease. Hepatology. 1993;17:977–986
  48. Li J, Kim CI, Leo MA, Mak KM, Rojkind M, Lieber CS. Polyunsaturated lecithin prevents acetaldehyde-mediated hepatic collagen accumulation by stimulating collagenase activity in cultured lipocytes. Hepatology. 1992;15:373–381
  49. Lieber CS. Medical and Nutritional Complications of Alcoholism: Mechanisms and Management. New York: Plenum Press; 1992;
  50. Lieber CS. Cytochrome P-4502E1: its physiological and pathological role. Physiol Rev. 1997;77:517–544
  51. Lieber CS. Microsomal ethanol-oxidizing system (MEOS): the first 30 years (1968–1998)—a review. Alcohol Clin Exp Res. 1999;23:991–1007
  52. Lieber CS. Alcoholic liver disease: new insights in pathogenesis lead to new treatments. J Hepatol. 2000;32(suppl 1):113–128
  53. Lieber CS. Alcoholic liver injury: pathogenesis and therapy in 2001. Pathol Biol (Paris). 2001;49:738–752
  54. Lieber CS, Baraona E, Hernández-Muñoz R, Kubota S, Sato N, Kawano S, et al. Impaired oxygen utilization: a new mechanism for the hepatotoxicity of ethanol in sub-human primates. J Clin Invest. 1989;83:1682–1690
  55. Lieber CS, Casini A, DeCarli LM, Kim CI, Lowe N, Sasaki R, et al. S-adenosyl-l-methionine attenuates alcohol-induced liver injury in the baboon. Hepatology. 1990;11:165–172
  56. Lieber CS, DeCarli LM. Ethanol oxidation by hepatic microsomes: adaptive increase after ethanol feeding. Science. 1968;162:917–918
  57. Lieber CS, DeCarli LM. Quantitative relationship between amount of dietary fat and severity of the alcoholic fatty liver. Am J Clin Nutr. 1970;23:474–478
  58. Lieber CS, DeCarli LM. An experimental model of alcohol feeding and liver injury in the baboon. J Med Primatol. 1974;3:153–163
  59. Lieber CS, DeCarli LM. Oxidation of ethanol by hepatic microsomes of acatalasemic mice. Biochem Biophys Res Commun. 1974;60:1187–1192
  60. Lieber CS, DeCarli LM, Schmid R. Effects of ethanol on fatty acid metabolism in liver slices. Biochem Biophys Res Commun. 1959;1:302–306
  61. Lieber CS, Jones DP, DeCarli LM. Effects of prolonged ethanol intake: production of fatty liver despite adequate diets. J Clin Invest. 1965;44:1009–1021
  62. Lieber CS, Jones DP, Mendelson J, DeCarli LM. Fatty liver, hyperlipemia and hyperuricemia produced by prolonged alcohol consumption, despite adequate dietary intake. Trans Assoc Am Physicians. 1963;76:289–300
  63. Lieber CS, Lefèvre A, Spritz N, Feinman L, DeCarli LM. Difference in hepatic metabolism of long- and medium-chain fatty acids: the role of fatty acid chain length in the production of the alcoholic fatty liver. J Clin Invest. 1967;46:1451–1460
  64. Lieber CS, Leo MA, Aleynik SI, Aleynik MK, DeCarli LM. Polyenylphosphatidylcholine decreases alcohol-induced oxidative stress in the baboon. Alcohol Clin Exp Res. 1997;21:375–379
  65. Lieber CS, Leo MA, Aleynik SI, Lowe N, Aleynik MK, Paronetto F. Increasing circulating level of dilinoleoylphosphatidylcholine is associated with protection against alcohol induced oxidative stress and liver fibrosis in man. Hepatology. 2000;32:386A;(Abstract)
  66. Lieber CS, Leo MA, Cao Q, Ren C, DeCarli LM. Silymarin retards the progression of alcohol-induced hepatic fibrosis in baboons. J Clin Gastroenterol. 2003;37:336–339
  67. Lieber CS, Robins SJ, Leo MA. Hepatic phosphatidylethanolamine methytransferase activity is decreased by ethanol and increased by phosphatidylcholine. Alcohol Clin Exp Res. 1994;18:592–595
  68. Lieber CS, Robins SJ, Li J, DeCarli LM, Mak KM, Fasulo JM, et al. Phosphatidylcholine protects against fibrosis and cirrhosis in the baboon. Gastroenterology. 1994;106:152–159
  69. Lieber CS, Schmid R. The effect of ethanol on fatty acid metabolism: stimulation of hepatic fatty acid synthesis in vitro. J Clin Invest. 1961;40:394–399
  70. Lieber CS, Weiss DG, Groszmann R, Paronetto F, Schenker S, for the Veterans Affairs Cooperative Study 391 Group . I. Veterans Affairs Cooperative Study of polyenylphosphatidylcholine in alcoholic liver disease: effects on drinking behavior by nurse/physician teams. Alcohol Clin Exp Res. 2003;27:1757–1764
  71. Lieber CS, Weiss DG, Groszmann R, Paronetto F, Schenker S, for the Veterans Affairs Cooperative Study 391 Group . II. Veterans Affairs Cooperative Study of polyenylphosphatidylcholine in alcoholic liver disease. Alcohol Clin Exp Res. 2003;27:1765–1772
  72. Ma X, Baraona E, Goozner BG, Lieber CS. Gender differences in medium-chain dicarboxylic aciduria in alcoholic men and women. Am J Med. 1999;106:70–75
  73. Ma X, Baraona E, Lieber CS. Alcohol consumption enhances fatty acid ω-oxidation, with a greater increase in male than in female rats. Hepatology. 1993;18:1247–1253
  74. Ma X, Svegliati-Baroni G, Poniachik J, Baraona E, Lieber CS. Collagen synthesis by liver stellate cells is released from its normal feedback regulation by acetaldehyde-induced modification of the carboxyl-terminal propeptide of procollagen. Alcohol Clin Exp Res. 1997;21:1204–1211
  75. Ma X, Zhao J, Lieber CS. Polyenylphosphatidylcholine attenuates non-alcoholic hepatic fibrosis and accelerates its regression. J Hepatol. 1996;24:604–613
  76. Mak KM, Leo MA, Lieber CS. Alcoholic liver injury in baboons: transformation of lipocytes to transitional cells. Gastroenterology. 1984;87:188–200
  77. Mak KM, Lieber CS. Lipocytes and transitional cells in alcoholic liver disease: a morphometric study. Hepatology. 1988;8:1027–1033
  78. Mato JM, Cámara J, Fernández de Paz J, Caballería L, Coll S, Caballero A, et al. S-Adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial. J Hepatology. 1999;30:1081–1089
  79. Meldolesi J. On the significance of the hypertrophy of the smooth endoplasmic reticulum in liver cells after administration of drugs. Biochem Pharmacol. 1967;16:125–131
  80. Mishra L, Sharma S, Potter JJ, Mezey E. More rapid elimination of alcohol in women as compared to their male siblings. Alcohol Clin Exp Res. 1989;13:752–754
  81. Miwa GT, Levin W, Thomas PE, Lu AYH. The direct oxidation of ethanol by a catalase- and alcohol dehydrogenase–free reconstituted system containing cytochrome P-4501. Arch Biochem Biophys. 1978;187:464–475
  82. Moshage H, Casini A, Lieber CS. Acetaldehyde selectively stimulates collagen production in cultured rat liver fat-storing cells but not in hepatocytes. Hepatology. 1990;12(3 Pt 1):511–518
  83. Navder KP, Baraona E, Lieber CS. Polyenylphosphatidylcholine attenuates alcohol-induced fatty liver and hyperlipemia in rats. J Nutr. 1997;127:1800–1806
  84. Nelson DR, Kamataki T, Waxman DJ, Guengerich FP, Estabrook RW, Feyereisen R, et al. The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA Cell Biol. 1993;12:1–51
  85. Niederau C, Strohmeyer G, Heintges T, Peter K, Gopfert E, for Leich Study Group . Polyunsaturated phosphatidyl-choline and interferon alpha for treatment of chronic hepatitis B and C: a multi-center, randomized, double-blind, placebo-controlled trial. Hepatogastroenterology. 1998;45:797–804
  86. Niemela O, Klajner F, Orrego H, Vidins E, Blendis L, Israel Y. Antibodies against acetaldehyde-modified protein epitopes in human alcoholics. Hepatology. 1987;7:1210–1214
  87. Ohnishi K, Lieber CS. Reconstitution of the microsomal ethanol-oxidizing system: qualitative and quantitative changes of cytochrome P-450 after chronic ethanol consumption. J Biol Chem. 1977;252:7124–7131
  88. Oneta CM, Mak KM, Lieber CS. Dilinoleoylphosphatidylcholine selectively modulates lipopolysaccharide-induced Kupffer cell activation. J Lab Clin Med. 1999;134:466–470
  89. Parés A, Planas R, Torres M, Caballería J, Viver JM, Acero D, et al. Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial. J Hepatol. 1998;28:615–621
  90. Poniachik J, Baraona E, Zhao J, Lieber CS. Dilinoleoylphosphatidylcholine decreases hepatic stellate cell activation. J Lab Clin Med. 1999;133:342–348
  91. Raucy JL, Lasker JM, Kraner JC, Salazar DE, Lieber CS, Corcoran GB. Induction of cytochrome P450IIE1 in the obese overfed rat. Mol Pharmacol. 1991;39:275–280
  92. Reichard GA, Skutches CL, Hoeldtke RD, Owen OE. Acetone metabolism in humans during diabetic ketoacidosis. Diabetes. 1986;35:668–674
  93. Roach MK, Resse WN, Creaven PJ. Ethanol oxidation in the microsomal fraction of rat liver. Biochem Biophys Res Commun. 1969;36:596–602
  94. Salmela KS, Kessova IG, Tsyrlov IB, Lieber CS. Respective roles of human cytochrome P-4502E1, 1A2, and 3A4 in the hepatic microsomal ethanol oxidizing system. Alcohol Clin Exp Res. 1998;22:2125–2132
  95. Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK, et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology. 2001;120:1183–1192
  96. Savolainen ER, Leo MA, Timpl R, Lieber CS. Acetaldehyde and lactate stimulate collagen synthesis of cultured baboon liver myofibroblasts. Gastroenterology. 1984;87:777–787
  97. Shevchuk O, Baraona E, Ma XL, Pignon JP, Lieber CS. Gender differences in the response of hepatic fatty acids and cytosolic fatty acid–binding capacity to alcohol consumption in rats. Proc Soc Exp Biol Med. 1991;198:584–590
  98. Takahashi T, Lasker JM, Rosman AS, Lieber CS. Induction of cytochrome P-4502E1 in the human liver by ethanol is caused by a corresponding increase in encoding messenger RNA. Hepatology. 1993;17:236–245
  99. Tephly TR, Tinelli F, Watkins WD. Alcohol metabolism: role of microsomal oxidation in vivo. Science. 1969;166:627–628
  100. Teschke R, Hasumura Y, Joly J-G, Lieber CS. Microsomal ethanol-oxidizing system (MEOS): purification and properties of a rat liver system free of catalase and alcohol dehydrogenase. Biochem Biophys Res Commun. 1972;49:1187–1193
  101. Teschke R, Hasumura Y, Lieber CS. Hepatic microsomal alcohol-oxidizing system in normal and acatalasemic mice: its dissociation from the peroxidatic activity of catalase-H2O2. Mol Pharmacol. 1975;11:841–849
  102. Teschke R, Matsuzaki S, Ohnishi K, DeCarli LM, Lieber CS. Microsomal ethanol oxidizing system (MEOS): current status of its characterization and its role. Alcohol Clin Exp Res. 1977;1:7–15
  103. Thurman RG, Brentzel HJ. The role of alcohol dehydrogenase in microsomal ethanol oxidation and the adaptive increase in ethanol metabolism due to chronic treatment with ethanol. Alcohol Clin Exp Res. 1977;1:33–38
  104. Thurman RG, Ley HG, Scholz R. Hepatic microsomal ethanol oxidation. Hydrogen peroxide formation and the role of catalase. Eur J Biochem. 1972;25:420–430
  105. Tsutsumi M, Lasker JM, Shimizu M, Rosman AS, Lieber CS. The intralobular distribution of ethanol-inducible P450IIE1 in rat and human liver. Hepatology. 1989;10:437–446
  106. Umeno M, McBride OW, Yang CS, Gelboin HV, Gonzalez FJ. Human ethanol-inducible P450IIE1: complete gene sequence, promoter characterization, chromosome mapping, and cDNA-directed expression. Biochemistry. 1988;27:9006–9013
  107. Umeno M, Song BJ, Kozak C, Gelboin HV, Gonzalez FJ. The rat P450IIE1 gene: complete intron and exon sequence, chromosome mapping, and correlation of developmental expression with specific 5′ cytosine demethylation. J Biol Chem. 1988;263:4956–4962
  108. Vatsis KP, Schulman MP. Absence of ethanol metabolism in “acatalatic” hepatic microsomes that oxidize drugs. Biochem Biophys Res Commun. 1973;52:588–594
  109. Vatsis KP, Schulman MP. An unidentified constituent of ethanol oxidation in hepatic microsomes. Fed Proc. 1974;33:554A;(Abstract)
  110. Vendemiale G, Altomare E, Trizio T, Le Grazie C, Di Padova C, Salerno MT, et al. Effects of oral S-adenosyl-l-methionine on hepatic glutathione in patients with liver disease. Scand J Gastroenterol. 1989;24:407–415
  111. Weltman MD, Farrell GC, Hall P, lngelman-Sundberg M, Liddle C. Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis. Hepatology. 1998;27:128–133
  112. Wondergem R, Davis J. Ethanol increases hepatocyte water volume. Alcohol Clin Exp Res. 1994;18:1230–1236
  113. Yamada S, Mak KM, Lieber CS. Chronic ethanol consumption alters rat liver plasma membranes and potentiates release of alkaline phosphatase. Gastroenterology. 1985;88:1799–1806
  114. Yang CS, Yoo JS, Ishizaki H, Hong JY. Cytochrome P450IIE1: roles in nitrosamine metabolism and mechanisms of regulation. Drug Metab Rev. 1990;22:147–159
  115. Ziegler DM. Discussion. In:  Estabrook RW,  Gillette RJ,  Lieberman KC editor. Microsomes and Drug Oxidations. Baltimore: Williams & Wilkins; 1972;p. 458

PII: S0741-8329(04)00156-9

doi: 10.1016/j.alcohol.2004.07.008

Alcohol
Volume 34, Issue 1 , Pages 9-19 , August 2004

Article Tools

* Image Usage & Resolution